|
ABT
|
Abbott Laboratories
|
US
|
NYSE
|
|
ALLK
|
Allakos Inc.
|
US
|
NASDAQ
|
|
ALRN
|
Aileron Therapeutics, Inc.
|
US
|
NASDAQ
|
|
AMGN
|
Amgen Inc.
|
US
|
NASDAQ
|
|
AMPE
|
Ampio Pharmaceuticals, Inc.
|
US
|
AMEX
|
|
ANAB
|
AnaptysBio, Inc.
|
US
|
NASDAQ
|
|
ARGX
|
argenx SE
|
US
|
NASDAQ
|
|
ARTL
|
Artelo Biosciences, Inc.
|
US
|
NASDAQ
|
|
ATNF
|
180 Life Sciences Corp.
|
US
|
NASDAQ
|
|
AZN
|
Astrazeneca PLC
|
US
|
NASDAQ
|
|
BJDX
|
Bluejay Diagnostics, Inc.
|
US
|
NASDAQ
|
|
CBIO
|
Catalyst Inc.
|
US
|
NASDAQ
|
|
CNTB
|
Connect Biopharma Holdings Limited
|
US
|
NASDAQ
|
|
CTXR
|
Citius Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
DICE
|
DICE Therapeutics, Inc.
|
US
|
NASDAQ
|
|
EQ
|
Equillium, Inc.
|
US
|
NASDAQ
|
|
EYPT
|
EyePoint Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
GILD
|
Gilead Sciences, Inc.
|
US
|
NASDAQ
|
|
GLPG
|
Galapagos NV
|
US
|
NASDAQ
|
|
GLTO
|
Galecto, Inc.
|
US
|
NASDAQ
|